Q Interbody Instruments
K2m, Inc. · Decision date Feb 6, 2026
What did the FDA decide?
FDA records K252873 as a 510(k) premarket notification, with a decision dated Feb 6, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Neurology
- Decision date
- Feb 6, 2026
Regulatory record facts
- Identifier
- K252873
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- K2m, Inc.
- Product code
- OLO
- Decision code
- SESE
- Decision date
- Feb 6, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Orthopedic Stereotaxic Instrument.
FDA decision timeline
K252873 received
Application receipt date recorded by FDA.
K252873 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code OLO
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
GPS AnkleK262567 | Blue Ortho | 510(k) clearance | Oct 26, 2026 | FDA |
7D Surgical System (10-0001)K260403 | 7D Surgical ULC | 510(k) clearance | Oct 19, 2026 | FDA |
| THINK Surgical, Inc. | 510(k) clearance | Oct 16, 2026 | FDA | |
| CarboFix Orhtopedics , Ltd. | 510(k) clearance | Oct 9, 2026 | FDA | |
| Brainlab SE | 510(k) clearance | Sep 30, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
K2m, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Leesburg, VA
Sources and methodology
- Original FDA record: K252873
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



